J. B. Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)
India
· Delayed Price · Currency is INR 1,882.55
+28.50 (1.54%)
Oct 30, 2024, 3:29 PM IST
JBCHEPHARM Revenue
J. B. Chemicals & Pharmaceuticals had revenue of 10.04B INR in the quarter ending June 30, 2024, with 12.07% growth. This brings the company's revenue in the last twelve months to 35.92B, up 10.17% year-over-year. In the fiscal year ending March 31, 2024, J. B. Chemicals & Pharmaceuticals had annual revenue of 34.84B with 10.63% growth.
Revenue (ttm)
35.92B
Revenue Growth
+10.17%
P/S Ratio
n/a
Revenue / Employee
6.76M
Employees
5,311
Market Cap
291.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
| Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
| Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
| Mar 31, 2021 | 20.43B | 2.68B | 15.09% |
| Mar 31, 2020 | 17.75B | 1.32B | 8.00% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionJ. B. Chemicals & Pharmaceuticals News
- 5 days ago - Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside - Business Upturn
- 24 days ago - Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83% - Business Upturn
- 4 weeks ago - Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance - Business Upturn
- 5 weeks ago - JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28% - Business Upturn